Literature DB >> 23605431

[Not Available].

G H Degen1.   

Abstract

Ochratoxin A (OTA) is an important food and feed contaminant with potential adverse effects in humans and animals. In view of present discussions on limit values for OTA in foods, essential elements of a toxicological risk assessment are outlined. The exposure situation in Europe is now well documented. The data base, with respect to a characterization of hazard and dose-response relationships, allowed to calculate a provisional tolerable daily intake for OTA suited to protect the consumer against undesirable toxic effects. Nonetheless, further research on OTA is indicated in view of unresolved issues regarding the following points: 1. mechanisms of action (mode of genotoxicity, role of bioactivation/metabolism, identification of DNA-adducts and dose-dependency); 2. combinations of OTA and other mycotoxins (studies of relevant mixtures/conditions); 3. individual susceptibility and/or situation-based vulnerability. Better information on mechanistic aspects of mycotoxin-induced toxicities will further improve our knowledge on the "margin of safety" between a given exposure and a potential impairment of human health.

Entities:  

Year:  2000        PMID: 23605431     DOI: 10.1007/BF02942997

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  13 in total

Review 1.  Mycotoxins: their implications for human and animal health.

Authors:  J Fink-Gremmels
Journal:  Vet Q       Date:  1999-10       Impact factor: 3.320

2.  Ochratoxin A in food and feed: occurrence, legislation and mode of action.

Authors:  D Höhler
Journal:  Z Ernahrungswiss       Date:  1998-03

Review 3.  Risk assessment of ochratoxin A: an update.

Authors:  T Kuiper-Goodman
Journal:  Food Addit Contam       Date:  1996

4.  Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes.

Authors:  S Obrecht-Pflumio; T Chassat; G Dirheimer; D Marzin
Journal:  Mutat Res       Date:  1999-10-29       Impact factor: 2.433

5.  Oxidation of ochratoxin A by an Fe-porphyrin system: model for enzymatic activation and DNA cleavage.

Authors:  I G Gillman; T N Clark; R A Manderville
Journal:  Chem Res Toxicol       Date:  1999-11       Impact factor: 3.739

Review 6.  Ochratoxin A in blood and its pharmacokinetic properties.

Authors:  R Fuchs; K Hult
Journal:  Food Chem Toxicol       Date:  1992-03       Impact factor: 6.023

Review 7.  Risk assessment of the mycotoxin ochratoxin A.

Authors:  T Kuiper-Goodman; P M Scott
Journal:  Biomed Environ Sci       Date:  1989-09       Impact factor: 3.118

Review 8.  Pharmacokinetics of ochratoxin A in animals.

Authors:  P Galtier
Journal:  IARC Sci Publ       Date:  1991

9.  Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction.

Authors:  M Castegnaro; U Mohr; A Pfohl-Leszkowicz; J Estève; J Steinmann; T Tillmann; J Michelon; H Bartsch
Journal:  Int J Cancer       Date:  1998-07-03       Impact factor: 7.396

Review 10.  The etiology of Balkan endemic nephropathy: still more questions than answers.

Authors:  C A Tatu; W H Orem; R B Finkelman; G L Feder
Journal:  Environ Health Perspect       Date:  1998-11       Impact factor: 9.031

View more
  3 in total

1.  Induction of micronuclei by ochratoxin A is a sensitive parameter of its genotoxicity in cultured cells.

Authors:  W Föllmann; C Behm; G H Degen
Journal:  Mycotoxin Res       Date:  2007-06       Impact factor: 3.833

2.  Exposure of neonates to ochratoxin A: first biomonitoring results in human milk (colostrum) from Chile.

Authors:  Katherine Muñoz; Victor Campos; Meinolf Blaszkewicz; Mario Vega; Alejandro Alvarez; Jorge Neira; Gisela H Degen
Journal:  Mycotoxin Res       Date:  2010-02-06       Impact factor: 3.833

3.  Modulation of ochratoxin A induced DNA-damage in urothelial cell cultures.

Authors:  G H Degen; S Lebrun; Y Lektarau; W Föllmann
Journal:  Mycotoxin Res       Date:  2005-03       Impact factor: 3.833

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.